Lung endothelial heparan sulfates mediate cationic peptide-induced barrier dysfunction: A new role for the glycocalyx

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 5 29-5, 2003, Pages

  Dull, Randal O ^a,c   Dinavahi, Ramani ^a   Schwartz, Lawrence ^a   Humphries, Donald E ^d   Berry, David ^b   Sasisekharan, Ram ^b   Garcia, Joe G N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Endothelium; Inflammation; Permeability

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARGININE; CATION; CELL SURFACE RECEPTOR; GLYCOSAMINOGLYCAN; HEPARIN LYASE; HEPARINASE 1; HEPARINASE 3; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN KINASE INHIBITOR; PEPTIDE; POLYARGININE; POLYMER; PROTEOHEPARAN SULFATE; SYNAPTOPHYSIN; SYNDECAN; SYNDECAN 1; SYNDECAN 4; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; BLOOD VESSEL PERMEABILITY; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; GLYCOCALYX; HYPOTHESIS; INFLAMMATION; LUNG ENDOTHELIUM; MICROVASCULATURE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0142182021     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00022.2003     Document Type: Review

References (42)

1. Arfors KE, Lundberg C, Lindbom L, Lundberg K, Beatty PG, and Harlan JM. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 69: 338-340, 1987.
2. Berry D, Shriver Z, Natke B, Kwan CP, Ventkataraman G, and Sasisekharan R. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1. Biochem J 373: L241-L249, 2003.
3. Borregaard N and Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521, 1997.
4. Capila I and Linhardt RJ. Heparin-protein interactions. Agnew Chem Int Ed Engl 41: 391-412, 2002.
5. Couchman JR and Woods A. Syndecan-4 and integrins: combinatorial signaling in cell adhesion. J Cell Sci 112: 3415-3420, 1999.
6. Curry FE and Michel CC. A fiber matrix model of capillary permeability. Microvasc Res 20: 96-99, 1980.
7. Dudek SM and Garcia JGN. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
8. Garcia JGN, Davis HW, and Patterson CE. Regulation of endothelial gap formation and barrier dysfunction. Role of myosin light chain phosphorylation. J Cell Physiol 163: 510-522, 1995.
9. Garcia JGN, Lazar V, Gilbert-McClain LI, Gallagher PJ, and Verin AD. Myosin light chain kinase in endothelium: molecular cloning and regulation. Am J Respir Cell Mol Biol 16: 489-494, 1997.
10. Garcia JGN, Schaphorst KL, Shi S, Verin AD, Hart CM, Callahan KS, and Patterson CE. Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 273: L172-L184, 1997.
11. Garcia JGN, Wang P, Schaphorst KL, Becker PM, Borbiev T, Liu F, Birukova A, Jacobs K, Bogatcheva N, and Verin AD. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J 16: 1064-1076, 2002.
12. Gautum N, Olofsson AM, Herwald H, Iverson LF, Lundgern-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, and Lindbom L. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of endothelial permeability. Nat Med 7: 1123-1127, 2001.
13. Giaever I and Keese CR. A morphological biosensor for mammalian cells. Nature 366: 591-592, 1993.
14. Horowitz A, Tkachenko E, and Simons M. Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J Cell Biol 157: 715-725, 2002.
15. Hu X and Weinbaum S. A new view of Starling's hypothesis at the microstructural level. Microvasc Res 58: 281-304, 1999.
16. Humphries DE, Lee SL, Fanburg BL, and Silbert JE. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells. J Cell Physiol 126: 249-253, 1986.
17. Humphries DE and Silbert JE. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 154: 365-371, 1988.
18. 1-integrin-dependent cell spreading. J Cell Biol 1495: 1143-1155, 2000.
19. Kaslovsky RA, Horgan MJ, Lum H, McCandless BK, Gilboa N, Wright D, and Malik AB. Pulmonary edema induced by phagocytosing neutrophils. Protective effect of monoclonal antibody against phagocyte CD18 integrin. Circ Res 67: 795-802, 1990.
20. Keiser N, Venkataraman G, Shriver Z, and Sasisekharan R. Direct isolation and sequencing of specific protein-binding by glycosaminoglycans. Nat Med 7: 123-128, 2001.
21. Langford JK, Stanely MJ, Coa D, and Sanderson RD. Multiple heparan sulfate chains are required for optimal syndecan-1 function. J Biol Chem 273: 29965-29971, 1998.
22. Lehr HA, Bittinger F, and Kirkpatrick CJ. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy. J Pathol 190:373-386, 2000.
23. Ley K. Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants. Immunol Res 24: 87-95, 2001.
24. Liu Y, Stack SM, Lakka SS, Khan AJ, Woodley DT, Rao JS, and Rao CN. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin. Arch Biochem Biophys 370: 112-118, 1999.
25. Lush CW and Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 7: 83-101, 2000.
26. Menger MD and Vollmar B. Role of the microcirculation in transplantation. Microcirculation 7: 291-306, 2000.
27. Michel CC, Phillips ME, and Turner MR. The effects of native and modified bovine serum albumin on the permeability of frog mesenteric capillaries. J Physiol 360: 333-346, 1985.
28. Nader HB, Kobayashi EY, Chavante SF, Tersarioli ILS, Castro RAB, Shinjo SK, Naggi A, Torri G, Casu B, and Dietrich CP. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Glycoconj J 16: 265-270, 1999.
29. Natarajan V, Scribner M, Moris AJ, Roy S, Vepa S, Yang J, Wadganokar R, Reddy SPM, Garcia JGN, and Parinandi NL. Role of p38 MAP kinase in pervanadate-induced phospholipase D activation in endothelial cells. Am J Physiol Lung Cell Mol Physiol 281: L435-L449, 2001.
30. Needham L, Hellewell PG, Williams TJ, and Gordon JL. Endothelial functional responses and increased vascular permeability induced by polycations. Lab Invest 58: 538-548, 1988.
31. Olofsson AM, Vestberg M, Herwald H, Rygaard J, David G, Arfors KE, Linde V, Flodgaard H, Dedio J, Muller-Esterl W, and Lundgren-Akerlund E. Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis. J Clin Invest 104: 885-894, 1999.
32. Patterson CE, Davis HW, Schaphorst K, and Garcia JGN. Mechanisms of pertussis toxin-induced barrier dysfunction in bovine pulmonary artery endothelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 268: L926-L934, 1995.
33. Pereira HA, Erdem I, Pohl J, and Spitznagel JK. Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci USA 90: 4733-4735, 1993.
34. Pereira HA, Shafer WM, Pohl J, Martin LE, and Spitznagel JK. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 85: 1468-1476, 1990.
35. Powers MR, Blumenstock FA, Cooper JA, and Malik AB. Role of albumin arginyl sites in albumin-induced reduction of endothelial hydraulic conductivity. J Cell Physiol 141: 558-564, 1989.
36. Pries AR, Secomb TW, and Gaehtgens P. The endothelial surface layer. Pflügers Arch 440: 653-666, 2000.
37. Sanderson RD, Turnbull JE, Gallagher JT, and Lander AD. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem 269: 13100-13106, 1994.
38. Saoncella S, Echtermeyer F, Denhaz F, Nowlen JK, Mosher DF, Robinson SD, Hynes R, and Goetinck PF. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci USA 96: 2805-2810, 1999.
39. Saumon G, Soler P, and Martet G. Effects of polycations on barrier and transport properties of alveolar epithelium in situ. Am J Physiol Lung Cell Mol Physiol 269: L185-L194, 1995.
40. Vepa S, Scribner WM, and Natarajan V. Activation of endothelial cell phospholipase D by polycations. Am J Physiol Lung Cell Mol Physiol 272: L608-L613, 1997.
41. Verin AD, Birukov A, Wang P, Lui F, Becker P, Birukov K, and Garcia JGN. Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 281: L565-L574, 2001.
42. Zimmermann P and David G. The syndecans, tuners of transmembrane signaling. FASEB J 13: S91-S100, 1999.